Company intelligence
Color
Care for cancer. Reinvented.
About Color
Color has reinvented the approach to cancer and created a single partner for accessible, clinical care across the entire cancer journey. By focusing on three main levers—access, speed, and direct clinical care—Color’s ASCO-certified, oncologist-led team identifies and manages your high-risk members no matter where they live, detects cancer earlier, improves clinical outcomes and costs for those in active treatment, and keeps survivors healthy to minimize recurrence. This cancer command center approach drives enrollment of 20%, increases screening adherence by 77%, cuts time to diagnosis and treatment by 66%, closes >75% of clinical care gaps, saves $62k on average per patient in treatment, and delivers 3.8:1 ROI in year one.
Verified activity
Signals from Color
7 published signals
Partnerships
Color announced a recent partnership with Judi Health.
Reported by Lauren Schindel (she/her)
Partnerships
Color has partnered with Judi Health, a leading enterprise health technology company and benefits administrator, to offer Color’s Virtual Cancer Clinic (VCC) to employees across the full cancer journey.
Reported by Color
Partnerships
Color partnered with Judi Health to access Color's Virtual Cancer Clinic to 5 million plus members nationally.
Reported by Alexandra Anderson
Partnerships
Color partnered with Judi Health to help more employers address one of their fastest-growing healthcare challenges.
Reported by Nate Fournier
Presence & Recognition
Color is hosting a session at The Conference Board meeting in Chicago this September.
Reported by Matt Van Thuyne
Partnerships
Color partnered with Judi Health to access Color's Virtual Cancer Clinic to 5 million plus members nationally.
Reported by Martha Jane Walker
Legal & Regulatory
Color announced that the FDA approved Revolution Medicine's Rasonque (daraxonrasib) for metastatic pancreatic adenocarcinoma after it showed a doubling in survival rates during clinical trials.
Reported by Dany Matar